🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the possible benefits and side effects of adding...
Status
Terminated
Location
Ohio State University Comprehensive Cancer Center
Start Date
2021-09-27
Trial ID
NCT04956302
Treatments Being Tested
The purpose of this study was to combine the PDR001 checkpoint inhibitor wi...
Status
Completed
Location
UCLA Santa Monica Hematology / Oncology SC
Start Date
2016-10-14
Trial ID
NCT02890069
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of panobinosta...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2009-06
Trial ID
NCT00918333
Treatments Being Tested
The purpose of the study is to assess the benefit of panobinostat monothera...
Status
Terminated
Location
UCLA
Start Date
2009-02
Trial ID
NCT00777335
Treatments Being Tested
The blood brain barrier (BBB) prevents some drugs from successfully reachin...
Status
Terminated
Location
Columbia University Irving Medical Center / NewYork-Presbyterian Hospital
Start Date
2021-07-28
Trial ID
NCT04804709
Treatments Being Tested
RATIONALE: Panobinostat and sorafenib may stop the growth of tumor cells by...
Status
Terminated
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2009-03
Trial ID
NCT00873002
Treatments Being Tested
The purpose of this research study is to determine the safety of LBH589 as ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2010-02
Trial ID
NCT01065467
Treatments Being Tested
This will be a single arm Phase II study....
Status
Terminated
Location
Florida Cancer Specialists
Start Date
2008-01
Trial ID
NCT00594230
Treatments Being Tested
The ORBIT trial is part of a worldwide search for a functional cure of HIV....
Status
Unknown
Location
Erasmus Medical Centre
Start Date
2024-04
Trial ID
NCT06240520
The purpose of this study is to provide oral panobinostat (PAN) treatment t...
Status
No Longer Available
Location
Novartis Investigative Site
Start Date
TBD
Trial ID
NCT02568943
Treatments Being Tested